Vault-13

Frazier Life Sciences Management, L.P.

PALO ALTO, CA · CIK 1892134 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2021 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
Palo Alto, CA (main office)United States United Statesabout 44
San Diego, CAUnited States United States3

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$4.6bn reported value +18.2% vs Q1 2026
41positions
73.6%in top 10
6 new 8 added 2 reduced 3 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 7,679,684 $899.1m19.58% 19.58% UnchangedShares held: Q3 2025 6.8m, Q4 2025 6.8m, Q1 2026 7.7m, Q2 2026 7.7m
2 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 18,088,902 $613.0m13.35% 13.35% AddedShares held: Q3 2025 16.7m, Q4 2025 16.9m, Q1 2026 16.9m, Q2 2026 18.1m +1.1m +1,145,128 6.8%
3 ERASCA INC COM ERAS ERAS 24,975,188 $457.5m9.96% 9.96% AddedShares held: Q3 2025 22.7m, Q4 2025 22.7m, Q1 2026 24.7m, Q2 2026 25.0m +300.0k +300,000 1.2%
4 MBX BIOSCIENCES INC COM MBX MBX 6,652,013 $367.2m8.00% 8.00% UnchangedShares held: Q3 2025 6.7m, Q4 2025 6.7m, Q1 2026 6.7m, Q2 2026 6.7m
5 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 9,874,511 $258.9m5.64% 5.64% UnchangedShares held: Q3 2025 9.9m, Q4 2025 9.9m, Q1 2026 9.9m, Q2 2026 9.9m
6 TREVI THERAPEUTICS INC COM TRVI TRVI 9,939,447 $185.4m4.04% 4.04% ReducedShares held: Q3 2025 10.3m, Q4 2025 10.3m, Q1 2026 9.9m, Q2 2026 9.9m -100 -100 0.0%
7 KRYSTAL BIOTECH INC COM KRYS KRYS 481,307 $178.9m3.90% 3.90% UnchangedShares held: Q3 2025 688.5k, Q4 2025 488.5k, Q1 2026 481.3k, Q2 2026 481.3k
8 MAZE THERAPEUTICS INC COM MAZE MAZE 5,032,915 $150.2m3.27% 3.27% AddedShares held: Q3 2025 4.6m, Q4 2025 4.6m, Q1 2026 4.6m, Q2 2026 5.0m +465.6k +465,641 10.2%
9 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 12,466,489 $135.3m2.95% 2.95% UnchangedShares held: Q3 2025 12.5m, Q4 2025 12.5m, Q1 2026 12.5m, Q2 2026 12.5m
10 PALVELLA THERAPEUTICS INC NE COM PVLA PVLA 882,400 $134.8m2.94% 2.94% UnchangedShares held: Q3 2025 722.4k, Q4 2025 722.4k, Q1 2026 882.4k, Q2 2026 882.4k
11 BRIDGEBIO PHARMA INC COM BBIO BBIO 1,548,139 $115.3m2.51% 2.51% ReducedShares held: Q3 2025 3.8m, Q4 2025 3.5m, Q1 2026 3.4m, Q2 2026 1.5m -1.9m -1,900,000 -55.1%
12 DISC MEDICINE INC COM IRON IRON 1,354,852 $99.1m2.16% 2.16% UnchangedShares held: Q3 2025 1.4m, Q4 2025 1.3m, Q1 2026 1.4m, Q2 2026 1.4m
13 CYTOKINETICS INC COM NEW CYTK CYTK 1,159,879 $98.8m2.15% 2.15% UnchangedShares held: Q3 2025 890.4k, Q4 2025 934.6k, Q1 2026 1.2m, Q2 2026 1.2m
14 DYNE THERAPEUTICS INC COM DYN DYN 3,153,082 $70.0m1.53% 1.53% UnchangedShares held: Q3 2025 2.7m, Q4 2025 3.2m, Q1 2026 3.2m, Q2 2026 3.2m
15 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 225,155 $60.1m1.31% 1.31% AddedShares held: Q3 2025 133.3k, Q4 2025 133.3k, Q1 2026 133.3k, Q2 2026 225.2k +91.8k +91,822 68.9%
16 SAVARA INC COM SVRA SVRA 9,720,852 $59.9m1.30% 1.30% UnchangedShares held: Q3 2025 11.5m, Q4 2025 9.9m, Q1 2026 9.7m, Q2 2026 9.7m
17 PARABILIS MEDICINES INC COM PBLS PBLS 1,920,805 $52.6m1.14% 1.14% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.9m
18 AURA BIOSCIENCES INC COM AURA AURA 7,100,000 $50.4m1.10% 1.10% AddedShares held: Q3 2025 5.1m, Q4 2025 5.1m, Q1 2026 5.1m, Q2 2026 7.1m +2.0m +2,000,000 39.2%
19 ACHIEVE LIFE SCIENCES INC COM ACHV ACHV 7,614,836 $49.7m1.08% 1.08% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 7.6m
20 VOR BIOPHARMA INC COM NEW VOR VOR 2,543,939 $46.8m1.02% 1.02% UnchangedShares held: Q3 2025 0, Q4 2025 2.5m, Q1 2026 2.5m, Q2 2026 2.5m
21 ALLOGENE THERAPEUTICS INC COM ALLO ALLO 22,446,668 $46.7m1.02% 1.02% AddedShares held: Q3 2025 3.9m, Q4 2025 3.9m, Q1 2026 3.8m, Q2 2026 22.4m +18.6m +18,650,000 491.2%
22 TARSUS PHARMACEUTICALS INC COM TARS TARS 728,644 $45.9m1.00% 1.00% UnchangedShares held: Q3 2025 1.2m, Q4 2025 728.6k, Q1 2026 728.6k, Q2 2026 728.6k
23 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 4,009,240 $40.1m0.87% 0.87% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 4.0m, Q2 2026 4.0m
24 ALKERMES PLC SHS ALKS ALKS 700,647 $36.7m0.80% 0.80% UnchangedShares held: Q3 2025 700.6k, Q4 2025 700.6k, Q1 2026 700.6k, Q2 2026 700.6k
25 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 1,438,198 $36.4m0.79% 0.79% UnchangedShares held: Q3 2025 613.8k, Q4 2025 1.3m, Q1 2026 1.4m, Q2 2026 1.4m
26 ZAI LAB LTD ADR ZLAB ZLAB 1,902,320 $36.1m0.79% 0.79% UnchangedShares held: Q3 2025 1.6m, Q4 2025 1.9m, Q1 2026 1.9m, Q2 2026 1.9m
27 MANNKIND CORP COM NEW MNKD MNKD 6,600,000 $28.1m0.61% 0.61% AddedShares held: Q3 2025 0, Q4 2025 4.2m, Q1 2026 5.9m, Q2 2026 6.6m +700.0k +700,000 11.9%
28 DESIGN THERAPEUTICS INC COM DSGN DSGN 1,809,854 $26.2m0.57% 0.57% NewShares held: Q3 2025 2.0m, Q4 2025 521.0k, Q1 2026 0, Q2 2026 1.8m
29 ACLARIS THERAPEUTICS INC COM ACRS ACRS 4,925,374 $26.1m0.57% 0.57% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 4.9m, Q2 2026 4.9m
30 SHATTUCK LABS INC COM STTK STTK 3,750,000 $26.0m0.57% 0.57% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.8m
31 KAILERA THERAPEUTICS INC COMMON STOCK KLRA KLRA 1,100,000 $24.2m0.53% 0.53% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.1m
32 MONTE ROSA THERAPEUTICS INC COM GLUE GLUE 1,000,000 $24.2m0.53% 0.53% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.0m, Q2 2026 1.0m
33 LEXEO THERAPEUTICS INC COM LXEO LXEO 4,824,725 $22.5m0.49% 0.49% AddedShares held: Q3 2025 4.4m, Q4 2025 4.4m, Q1 2026 4.4m, Q2 2026 4.8m +400.0k +400,000 9.0%
34 RELAY THERAPEUTICS INC COM RLAY RLAY 1,015,693 $19.0m0.41% 0.41% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.0m
35 EVOLUS INC COM EOLS EOLS 2,630,665 $18.3m0.40% 0.40% UnchangedShares held: Q3 2025 2.6m, Q4 2025 2.6m, Q1 2026 2.6m, Q2 2026 2.6m
36 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 484,782 $15.4m0.34% 0.34% UnchangedShares held: Q3 2025 384.8k, Q4 2025 384.8k, Q1 2026 484.8k, Q2 2026 484.8k
37 VALNEVA SE SPONSORED ADS VALN VALN 2,291,666 $12.0m0.26% 0.26% UnchangedShares held: Q3 2025 2.3m, Q4 2025 2.3m, Q1 2026 2.3m, Q2 2026 2.3m
38 NEWAMSTERDAM PHARMA COMPANY *W EXP 11/22/202 NAMSW NAMSW 500,333 $10.7m0.23% 0.23% UnchangedShares held: Q3 2025 500.3k, Q4 2025 500.3k, Q1 2026 500.3k, Q2 2026 500.3k
39 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 4,447,910 $7.1m0.15% 0.15% UnchangedShares held: Q3 2025 4.6m, Q4 2025 4.6m, Q1 2026 4.4m, Q2 2026 4.4m
40 XILIO THERAPEUTICS INC COM XLO XLO 422,505 $4.0m0.09% 0.09% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 422.5k, Q2 2026 422.5k
41 IBIO INC COM NEW IBIO IBIO 1,953,467 $3.4m0.07% 0.07% UnchangedShares held: Q3 2025 0, Q4 2025 2.0m, Q1 2026 2.0m, Q2 2026 2.0m

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
KALVISTA PHARMACEUTICALS INC KALV KALV 4,961,108 $99.9m5.0m shares
REVOLUTION MEDICINES INC RVMD RVMD 675,686 $65.7m675.7k shares
AGIOS PHARMACEUTICALS INC AGIO AGIO 1,256,080 $42.5m1.3m shares